» Articles » PMID: 17241907

MHC Class I Antigens and Immune Surveillance in Transformed Cells

Overview
Journal Int Rev Cytol
Specialty Cell Biology
Date 2007 Jan 24
PMID 17241907
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune system, in particular, in the presentation of peptides as tumor-associated antigens to cytotoxic lymphocytes (CTLs) and in the regulation of cytolytic activity of natural killer (NK) cells. In this review we discuss the role of MHC class I antigens in the recognition and elimination of transformed cells and in the generation of tumor immune escape routes when MHC class I losses occur in tumors. The different altered MHC class I phenotypes and their distribution in different human tumors are the main topic of this review. In addition, molecular defects that underlie MHC alterations in transformed cells are also described in detail. Future research directions in this field are also discussed, including the laboratory analysis of tumor MHC class I-negative variants and the possible restoration of MHC class I expression.

Citing Articles

The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies.

Filipek-Gorzala J, Kwiecinska P, Szade A, Szade K Front Oncol. 2024; 14:1308709.

PMID: 38440231 PMC: 10910019. DOI: 10.3389/fonc.2024.1308709.


Epithelial recognition and elimination against aberrant cells.

Ayukawa S, Kamoshita N, Maruyama T Semin Immunopathol. 2024; 45(4-6):521-532.

PMID: 38411739 DOI: 10.1007/s00281-024-01001-0.


Association of HLA-A, B, and C alleles and cancer susceptibility in 179 solid malignancies.

Carabano M, Liu T, Liu A, Lee J, Cheng L, Wang L Am J Transl Res. 2023; 15(9):5642-5652.

PMID: 37854217 PMC: 10579009.


Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation.

Lee M, Ratanachan D, Wang Z, Hack J, Adbulrahman L, Shamlin N J Immunol. 2023; 211(4):693-705.

PMID: 37395687 PMC: 10435044. DOI: 10.4049/jimmunol.2100793.


The dichotomous role of immunoproteasome in cancer: Friend or foe?.

Chen B, Zhu H, Yang B, Cao J Acta Pharm Sin B. 2023; 13(5):1976-1989.

PMID: 37250147 PMC: 10213805. DOI: 10.1016/j.apsb.2022.11.005.